Skip to content

Sono-guided prolotherapy/ oxygen-ozone/ corticosteroid therapy for the treatment of musculoskeletal pain in physical and rehabilitation medicine: Interventional pain management for trochanteric bursitis: a prospective, randomized, double-blind, positive control, multicenter clinical trial.

Sono-guided prolotherapy/ oxygen-ozone/ corticosteroid therapy for the treatment of musculoskeletal pain in physical and rehabilitation medicine: Interventional pain management for trochanteric bursitis: a prospective, randomized, double-blind, positive control, multicenter clinical trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100827004641N16
Enrollment
48
Registered
2020-08-24
Start date
2020-01-18
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trochanteric bursitis. Trochanteric bursitis

Interventions

Intervention 1: Intervention group A :after providing sterile conditions with Povidone-Iodine solution, anesthesia is performed locally with 1 cc of 2% lidocaine and 22 gage needle. For all patients,

Sponsors

Iran university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
46 Years to 46 Years

Inclusion criteria

Inclusion criteria: Pain in the back of the trochanter that also has local tenderness

Exclusion criteria

Exclusion criteria: The presence of pathology in the hip joint Rheumatic disease Calcification at the injection site Any skin infection at the injection site History of injection or on-site physiotherapy in the last 2 month Coagulation disorders Existence of lumbosacral radiculopathy

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: Evaluating the visual analogue scale at the beginning of the study (before intervention) and 7 and 60 days after injection. Method of measurement: Visual analogue Scale.;Overall recovery rate. Timepoint: Evaluating the overall recovery rate at 7 and 60 days after injection. Method of measurement: Patient Global Impression of Improvement.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBina Eftekharsadat

Tabriz University of Medical Sciences

binasadat@tbzmed.ac.ir+98 41 1330 3193

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026